Skip to content

Leuprolide studies: 131 papers with results

Page 3 of 3

Leuprolide has 1,829 linked papers. PepBank read up to 120 of the most-cited studies that gave it to people, up to 20 other studies, and the main trials.

  1. Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report.

    Pereyra Pacheco B · Gynecologic oncology · 2001

    Non-randomized trial · 2 results

  2. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.

    Schlaff WD · Obstetrics and gynecology · 1989

    Non-randomized trial · 10 results

  3. The secretion of insulin-like growth factors I and II by explant cultures of fibroids and myometrium from women treated with a gonadotropin-releasing hormone agonist.

    Rein MS · Obstetrics and gynecology · 1990

    Non-randomized trial · 6 results

  4. Fasting serum growth hormone and insulin-like growth factor-I and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo.

    Friedman AJ · Fertility and sterility · 1990

    Non-randomized trial · 5 results

  5. Leuprolide acetate suppresses pedophilic urges and arousability.

    Schober JM · Archives of sexual behavior · 2005

    Non-randomized trial · 7 results

  6. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial.

    Green HJ · BJU international · 2004

    Non-randomized trial · 2 results

  7. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study.

    Mathias JR · Digestive diseases and sciences · 1994

    Non-randomized trial · 3 results

  8. Role of leuprolide acetate depot in hysteroscopic surgery: a controlled study.

    Perino A · Fertility and sterility · 1993

    Non-randomized trial · 3 results

  9. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).

    Mizutani T · The Journal of clinical endocrinology and metabolism · 1998

    Non-randomized trial · 4 results

  10. Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study.

    Rosenfield RL · The Journal of clinical endocrinology and metabolism · 1996

    Non-randomized trial · 6 results

  11. Goserelin versus leuprolide in the chemical castration of patients with prostate cancer.

    Dias Silva É · International urology and nephrology · 2012

    Non-randomized trial · 6 results

  12. Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment.

    Matalliotakis IM · Journal of reproductive immunology · 2001

    Non-randomized trial · 2 results

  13. Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib.

    Dogan E · Fertility and sterility · 2004

    Animal study (in vivo) · rat · 5 results

  14. High-dose atorvastatin causes regression of endometriotic implants: a rat model.

    Oktem M · Human reproduction (Oxford, England) · 2007

    Animal study (in vivo) · rat · 5 results

  15. Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys.

    Ataya K · Biology of reproduction · 1995

    Animal study (in vivo) · rhesus monkey · 3 results

  16. Leuprolide, a gonadotropin-releasing hormone agonist, enhances colonization after spermatogonial transplantation into mouse testes.

    Ogawa T · Tissue & cell · 1998

    Animal study (in vivo) · mouse · 1 result

  17. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy.

    Katsuno M · Nature medicine · 2003

    Animal study (in vivo) · mouse · 4 results

  18. Long-term survival of human spermatogonial stem cells in mouse testes.

    Nagano M · Fertility and sterility · 2002

    Animal study (in vivo) · mouse · 1 result

  19. Recipient preparation is critical for spermatogonial transplantation in the rat.

    Ogawa T · Tissue & cell · 1999

    Animal study (in vivo) · rat · 2 results

  20. Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice.

    Casadesus G · Biochimica et biophysica acta · 2006

    Animal study (in vivo) · mouse · 3 results

  21. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.

    Okada H · Pharmaceutical research · 1994

    Animal study (in vivo) · rat · 1 result

  22. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition.

    Bowen RL · The Journal of biological chemistry · 2004

    Animal study (in vivo) · mouse · 2 results

  23. Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin.

    Nakatani T · Japanese journal of cancer research : Gann · 2001

    Animal study (in vivo) · mouse · 3 results

  24. Effects of medical or surgical castration on erectile function in an animal model.

    Traish AM · Journal of andrology · 2003

    Animal study (in vivo) · rabbit · 6 results

  25. Reproductive hormones regulate the selective permeability of the blood-brain barrier.

    Wilson AC · Biochimica et biophysica acta · 2008

    Animal study (in vivo) · mouse · 3 results

  26. Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals.

    Ogawa Y · The Journal of pharmacy and pharmacology · 1989

    Animal study (in vivo) · dog and rat · 11 results

  27. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate.

    Okada H · Pharmaceutical research · 1991

    Animal study (in vivo) · rat · 7 results

  28. GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model.

    Hopmans SN · Urologic oncology · 2014

    Animal study (in vivo) · mouse · 12 results

  29. Gonadotropin-releasing hormone analogs stimulate and testosterone inhibits the recovery of spermatogenesis in irradiated rats.

    Shetty G · Endocrinology · 2000

    Animal study (in vivo) · rat · 9 results

  30. One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.

    Okada H · The Journal of pharmacology and experimental therapeutics · 1988

    Animal study (in vivo) · rat · 4 results

  31. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.

    Shahnaz G · International journal of pharmaceutics · 2012

    Not a test of Leuprolide alone · 5 results

How PepBank reports evidence